IS SERUM CA-125 AT THE TIME OF RELAPSE A PROGNOSTIC INDICATOR FOR FURTHER SURVIVAL PROGNOSIS IN PATIENTS WITH OVARIAN-CANCER

被引：25

作者：

MAKAR, AP

KRISTENSEN, GB

BORMER, OP

TROPE, CG

机构：

[1] NORWEGIAN RADIUM HOSP,DEPT GYNECOL ONCOL,N-0310 OSLO,NORWAY

[2] NORWEGIAN RADIUM HOSP,CENT LAB,N-0310 OSLO,NORWAY

来源：

GYNECOLOGIC ONCOLOGY | 1993年 / 49卷 / 01期

关键词：

D O I：

10.1006/gyno.1993.1076

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The prognostic significance of serum CA 125 level before treatment of relapse for invasive epithelial ovarian cancer has been evaluated in 135 patients. At time of relapse, serum CA 125 level was higher than 35 U/ml in 110 (82%) patients. Those with serum CA 125 level of 35 U/ml or less at relapse had a better prognosis than those with higher values. Among patients with serum CA 125 level higher than 35 U/ml no difference in survival was observed. By multivariate analysis the independent prognostic factors for survival were histologic type (P < 0.0001) and serum CA 125 level (P < 0.01). Randomized trials are needed to further evaluate whether early detection of disease relapse because of serial serum CA 125 measurements does have prognostic significance. © 1993 Academic Press, Inc.

引用

页码：3 / 7

页数：5

共 16 条

[11]

MAKAR AP, 1992, OBSTET GYNECOL, V79, P1002

[12]

Montag T W, 1990, Obstet Gynecol Surv, V45, P94, DOI 10.1097/00006254-199002000-00003

[13] THE CA 125 ASSAY AS A PREDICTOR OF CLINICAL RECURRENCE IN EPITHELIAL OVARIAN-CANCER [J].

NILOFF, JM ;

KNAPP, RC ;

LAVIN, PT ;

MALKASIAN, GD ;

BEREK, JS ;

MORTEL, R ;

WHITNEY, C ;

ZURAWSKI, VR ;

BAST, RC .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (01) :56-60

[14]

PETTERSSON F, 1989, ANN REPORT RESULTS T, V21

[15]

Serov SF, 1973, INT HISTOLOGICAL CLA, P17

[16] CA-125 RELIABILITY IN PREDICTING OVARIAN-CANCER RECURRENCE [J].

ZANABONI, F ;

PRESTI, M ;

SCARFONE, G ;

BOLIS, G .

TUMORI, 1989, 75 (01) :69-71

← 1 2 →